GLP-1 Cost: What Every GLP-1 Costs Per Month, With and Without Insurance (2026)
Pricing is accurate as of November 2026 and subject to change.
Key Takeaways
- As of November 2026, brand-name GLP-1s list for about $650 (Foundayo) to $1,349.02 (Wegovy and Saxenda) a month, and most injections list above $1,000.
- The makers' self-pay prices run $149 to $499 a month: Wegovy pens $349 after two $199 new-patient fills, the Wegovy pill and Foundayo $149 to $299, Zepbound vials and KwikPens $299 to $449, and Mounjaro $499.
- With commercial insurance that covers it, a manufacturer savings card can bring a GLP-1 to $25. The cards exclude Medicare and Medicaid, and Lilly's cards end December 31, 2026.
- Eligible Medicare Part D members pay $50 a month for Wegovy, Foundayo or the Zepbound KwikPen through the Medicare GLP-1 Bridge, from July 1, 2026 to December 31, 2027.
- Compounded semaglutide and tirzepatide cost about $76 to $432 a month at online programs, and the lowest prices often require paying for a year up front; they are not FDA-approved. At MaxLife they are $89/mo flat and $120/mo flat: the full price per month and the same price at every dose, with no membership fee.
- Novo Nordisk cuts the list price of Wegovy, Ozempic and Rybelsus to $675 a month on January 1, 2027; its self-pay prices don't change.

As of November 2026, a GLP-1 costs about $650 to $1,350 a month at list price, $149 to $499 a month through the drug makers' own self-pay programs, as little as $25 a month with commercial insurance that covers it and a manufacturer savings card, and $50 a month through the Medicare GLP-1 Bridge if you qualify. Most brand-name injections list above $1,000. What you actually pay depends on the drug, the dose, the form (pen, vial or pill) and your coverage. Compounded semaglutide and tirzepatide, which are not FDA-approved, cost about $76 to $432 a month at the online programs we track, but the lowest of those prices often require paying for a year up front, such as a yearly membership or a 12-month plan.
If you're paying cash, MaxLife's compounded semaglutide is $89/mo flat and compounded tirzepatide is $120/mo flat: the full price per month, the same at every dose, all-inclusive and with no membership fee, prescribed only if a licensed provider decides it's right for you. Compounded medicines are not FDA-approved, and they are not Wegovy®, Ozempic®, Zepbound® or Mounjaro®.
Below you'll find every GLP-1's list and self-pay price, what you'd pay in your situation, how savings cards and Medicare work, the cost per year, and what changes in 2027. To work out your own cost, try our free GLP-1 cost calculator.
How Much Does a GLP-1 Cost Per Month?
Most brand-name GLP-1s list for about $1,000 to $1,350 a month, but their makers sell them directly to cash-paying patients for $149 to $499. The list price, or wholesale acquisition cost (WAC), is what the manufacturer charges wholesalers before discounts. The self-pay price is what you pay the maker's pharmacy service without insurance. These are the prices as of November 2026.
GLP-1s approved for weight management:
| Drug and form | List price a month | Maker's self-pay price |
|---|---|---|
| Wegovy pen (semaglutide) | $1,349.02 | $199 for 2 fills, then $349 ($399 for HD 7.2 mg) |
| Wegovy pill (semaglutide) | $1,349.02 | $149 to $299 |
| Zepbound vial or KwikPen (tirzepatide) | $1,087 | $299 to $449 |
| Foundayo™ pill (orforglipron) | $649 | $149 to $299 |
| Saxenda® (liraglutide) | $1,349.02 | None listed; being discontinued |
GLP-1s approved for type 2 diabetes:
| Drug and form | List price a month | Maker's self-pay price |
|---|---|---|
| Ozempic pen (semaglutide) | $1,027.51 | $199 for 2 fills, then $349 to $499 |
| Ozempic pill (semaglutide) | $1,027.51 | $149 to $299 |
| Mounjaro pen (tirzepatide) | $1,112.16 | $499 |
| Trulicity® pen (dulaglutide) | $987.19 | $389 |
List prices come from TrumpRx.gov, the federal drug-price site, which labels them as the wholesale acquisition cost, and from NovoCare. Self-pay prices come from NovoCare Pharmacy and LillyDirect, checked in November 2026. A few rules sit behind the numbers:
- A pen or vial "month" is 28 days, so a year takes 13 fills. A pill month is 30 tablets.
- The $199 Wegovy and Ozempic prices are for a new patient's first two fills of the starting doses, through December 31, 2026.
- Zepbound costs $299 at 2.5 mg, $399 at 5 mg and $449 at 7.5 mg to 15 mg, but the $449 price needs a refill within 45 days. Later refills cost $499 or $699.
- Saxenda has no self-pay price from Novo Nordisk, which says it is discontinuing the brand, with last shipments to wholesalers in late January 2027 (NovoCare).
Both Wegovy and Ozempic contain semaglutide, and both Zepbound and Mounjaro contain tirzepatide. The FDA approved one of each pair for weight management (Wegovy, Zepbound) and the other for type 2 diabetes (Ozempic, Mounjaro), and insurers decide coverage by approved use. In February 2026 the FDA approved the Ozempic name for Novo Nordisk's newer semaglutide tablets for type 2 diabetes, now sold as the Ozempic pill; Rybelsus® is the original tablet (Novo Nordisk). For one medicine in depth, see our guides to semaglutide cost per month and tirzepatide cost per month.
What Will a GLP-1 Cost You? Cost by Situation
Your coverage decides your price more than the drug does. Find your situation below, or pick your medicine, dose and coverage in our GLP-1 cost calculator:
| Your situation | What you may pay a month | What to do first |
|---|---|---|
| Commercial plan covers your GLP-1 | As little as $25 with the maker's savings card | Enroll in the card; ask about prior authorization |
| Commercial plan excludes weight-loss drugs | $149 to $499 self-pay | Compare the makers' self-pay prices |
| High-deductible plan, deductible not met | Your plan's negotiated price | Ask what you'd pay before and after the deductible |
| Medicare Part D, weight loss only | $50 through the GLP-1 Bridge | Ask your doctor whether you qualify |
| Medicare with type 2 diabetes or sleep apnea | Your Part D plan's copay | Check your plan's drug list |
| Medicaid | Little or nothing, if your state covers it | Ask your state Medicaid plan |
| No insurance | $149 to $499 brand; about $76 to $432 compounded, the lowest with a year paid up front | Compare the full monthly cost (see our guide) |
Manufacturer savings cards don't work with Medicare, Medicaid, TRICARE, VA or other government coverage. You can still pay a maker's self-pay price outside your plan, but that purchase won't count toward your deductible or out-of-pocket limit (NovoCare, Lilly).
How Much Is a GLP-1 Without Insurance?
Without insurance, a brand-name GLP-1 costs $149 to $499 a month through the makers' self-pay programs as of November 2026. At a retail pharmacy without a discount, you may be charged close to the list price, so ask before you fill.
Novo Nordisk and Eli Lilly make the brand-name GLP-1s in this guide, and each sells them directly:
- Novo Nordisk sells Wegovy and Ozempic pens and pills through NovoCare Pharmacy, with home delivery. Wegovy pens cost $349 a month after a new patient's two $199 fills, and Wegovy HD 7.2 mg costs $399.
- Eli Lilly sells Zepbound vials and KwikPens, Mounjaro, Foundayo and Trulicity through LillyDirect. Mounjaro is $499 for all doses and Trulicity is $389 for all doses.
TrumpRx.gov lists the same self-pay prices next to each list price, with a pharmacy coupon for Wegovy and Ozempic and a link to LillyDirect for Lilly's medicines. It is a way to find the makers' offers, not a separate discount. Novo Nordisk also announced on March 31, 2026 a Wegovy subscription sold through select telehealth providers, as low as $249 a month for pens on a 12-month subscription (Novo Nordisk). Terms vary by platform, so ask whether a program fee is added.
Budget for supplies too. Zepbound vials need syringes and needles, and the KwikPen needs pen needles, which LillyDirect lists as a separate purchase.
Paying cash through an online program? Our guide to GLP-1 without insurance explains why the advertised price is often not what you pay:
- The intro price that expires: a low first month that rises afterward.
- The membership fee on top: a monthly or yearly fee charged separately from the medicine.
- The upfront commitment: the lowest rate only if you pay for several months or a year ahead.
It also covers what to check before you choose a program and how MaxLife's flat pricing works: compounded semaglutide $89/mo flat and tirzepatide $120/mo flat, the full price per month and the same price at every dose, with no membership fee. Compounded medicines are not FDA-approved. Read the full guide: GLP-1 without insurance, with nothing hidden.
How Much Do GLP-1 Pills Cost?
GLP-1 pills cost $149 to $299 a month through the makers' self-pay programs as of November 2026, less than most injections at the starting doses. You need a prescription, and NovoCare Pharmacy and LillyDirect can ship them to your home.
| Pill | Starting doses | Higher doses |
|---|---|---|
| Wegovy pill | $149 (1.5 mg) | $199 (4 mg); $299 (9 mg, 25 mg) |
| Foundayo | $149 (0.8 mg, 2.5 mg) | $199 (5.5 mg); $299 (9 mg to 17.2 mg) |
| Ozempic pill | $149 | Up to $299 |
Two details change the math. Foundayo's 2.5 mg and 5.5 mg prices are "temporarily reduced through December 31, 2026," according to LillyDirect; the regular prices are $199 and $299. Its two highest doses stay at $299 only if you refill within 45 days. And the Ozempic pill is approved for type 2 diabetes, while the Wegovy pill and Foundayo are approved for weight management. Because the price rises with the dose, plan your budget around the $299 tier, not the starting price.
How Much Does a GLP-1 Cost With Insurance?
With commercial insurance that covers your GLP-1, you may pay as little as $25 a month with the maker's savings card. If your plan doesn't cover it for your use, you pay the self-pay prices above.
Coverage for weight loss is still the exception. In KFF's 2026 employer survey, 18% of firms with 200 or more workers covered GLP-1s used mainly for weight loss, including 33% of firms with 5,000 or more workers (KFF). Plans cover these drugs far more often for type 2 diabetes. When a plan covers a weight-loss GLP-1, it usually requires prior authorization, which means your prescriber must show that you meet the plan's rules, such as a BMI threshold.
Here is what the savings cards offer as of November 2026:
| Savings card | Pay as little as | Limits and end date |
|---|---|---|
| Zepbound pen | $25 for a 1- to 3-month fill | Saves up to $100 a month, $1,300 a year; ends Dec 31, 2026 |
| Mounjaro | $25 for a 1- to 3-month fill | Saves up to $150 a month, $1,950 a year; ends Dec 31, 2026 |
| Foundayo | $25 for a 1- to 3-month fill | Saves up to $100 a month, $1,000 a year; ends Dec 31, 2026 |
| Trulicity | $25 for a 1- to 3-month fill | Saves up to $150 a month, $1,950 a year; ends Dec 31, 2026 |
| Wegovy or Ozempic | $25 a month | Saves up to $100 a month |
Sources: Zepbound, Mounjaro, Foundayo, Trulicity and Wegovy savings terms. If your copay is higher than the card's cap, you pay the difference. With a commercial plan that doesn't cover Zepbound, Lilly's card can bring the single-dose pen to $499 a month.
Will insurance cover Ozempic for weight loss? Usually not, because Ozempic is approved for type 2 diabetes, and plans pay for drugs based on the approved use and the diagnosis on the prescription. Our guide to weight loss drugs covered by insurance explains prior authorization and appeals step by step.
How Much Does a GLP-1 Cost With Medicare?
With Medicare Part D, a GLP-1 for weight loss costs $50 a month through the Medicare GLP-1 Bridge if you qualify. CMS runs this short-term program from July 1, 2026 to December 31, 2027, outside your Part D plan's regular benefit (CMS). According to Medicare.gov:
- Covered drugs: Foundayo, Wegovy (pen or pill) and the Zepbound KwikPen. Zepbound single-dose vials and pens are not covered.
- Who qualifies: adults 18 and older with Part D coverage and a BMI of 35 or higher; or a BMI of 30 or higher with diastolic heart failure, uncontrolled high blood pressure or chronic kidney disease stage 3a or higher; or a BMI of 27 or higher with prediabetes, a previous heart attack or stroke, or symptomatic peripheral artery disease.
- Who doesn't: people whose Part D plan already covers their GLP-1, and people with type 2 diabetes, moderate-to-severe sleep apnea or fatty liver disease, whose "Part D plan might cover your GLP-1s."
- How it works: your provider sends the prescription and, when asked, a prior authorization, and certifies that you're in a diet and exercise program. Approval lasts through December 31, 2027 unless you change GLP-1s.
CMS says the Part D deductible doesn't apply, the $50 doesn't count toward your out-of-pocket costs, and the Low-Income Subsidy doesn't lower it. Outside the Bridge, your Part D plan's own copay applies if it covers your GLP-1 for type 2 diabetes or another approved use.
Medicaid coverage for weight loss depends on your state. As of January 2026, 13 state Medicaid programs covered GLP-1s for obesity, usually with prior authorization, according to KFF.
How Much Do Compounded Semaglutide and Tirzepatide Cost?
Compounded GLP-1s usually cost less than brand-name injections, but they are a different kind of product. Compounded semaglutide or tirzepatide is prepared by a licensed pharmacy for one patient's prescription and is not FDA-approved, which means the FDA hasn't reviewed it for safety, effectiveness or quality. It is not a generic of Wegovy, Ozempic, Zepbound or Mounjaro, and insurance doesn't cover it.
Here is what online programs charged when we checked their own pages in November 2026, using each program's cheapest option with no added ingredients that ships to all 50 states:
- Compounded semaglutide: about $76 to $348 a month at the 27 programs that bill the medicine one month at a time (median $199), fees included. The $76 low end needs a $199 yearly membership paid up front, and paying ahead for a year brings the cheapest plans down to $53 to $99 a month. Details are in our guide to the cheapest semaglutide online.
- Compounded tirzepatide: $129 to about $432 a month at the 15 programs that bill one month at a time (median about $225). Over a full year, the median is about $141 a month at 18 programs, from about $107 to $422, often with several months or a full year paid up front. See the compounded tirzepatide price index.
The headline price is rarely the whole bill. Watch for a membership fee on top of the medicine, an advertised price that needs months paid up front, prices that rise with the dose, a formula with an added ingredient, and programs that don't serve every state.
At MaxLife, compounded semaglutide is $89/mo flat and compounded tirzepatide is $120/mo flat: the full price per month, all-inclusive, the same at every dose, with no membership fee and no hidden fees. The price covers a licensed provider's review and follow-up, the medicine if prescribed, supplies and free expedited shipping. MaxLife is a telehealth patient management platform, not a pharmacy, and does not produce medication. A licensed provider reviews your online intake, health history and clinical records, usually within 24 hours, can follow up with questions, and you can ask for a video visit. If the provider decides a prescription is right for you, licensed partner pharmacies prepare and ship it. MaxLife's compounded semaglutide is for weight management only. See compounded semaglutide and compounded tirzepatide at MaxLife.
A brand is the better route for some people. If your plan covers Wegovy or Zepbound and the savings card brings it to $25, or you qualify for the $50 Medicare Bridge, the brand will cost you less. If you need an approved use such as type 2 diabetes, heart-risk reduction (Wegovy) or sleep apnea (Zepbound), talk to your provider about the brand.
What Does a GLP-1 Cost Per Year?
A year of a brand-name GLP-1 costs about $3,200 to $6,500 at the makers' self-pay prices as of November 2026, and about $7,800 to $17,540 at list price. Here is our math for the main routes, with on-time refills and the dose steps in each FDA label:
| Route | 12 months | How we counted |
|---|---|---|
| Wegovy pen, list price | About $17,540 | 13 fills × $1,349.02 |
| Zepbound, list price | About $14,130 | 13 fills × $1,087 |
| Mounjaro, LillyDirect | $6,487 | 13 fills × $499 |
| Zepbound, LillyDirect | $5,637 | $299 + $399 + 11 × $449 |
| Wegovy pen, NovoCare, new patient | $4,237 | 2 × $199 + 11 × $349 |
| Wegovy pill, NovoCare | $3,338 | $149 + $199 + 10 × $299 |
| Foundayo, LillyDirect | $3,188 | $149 + $149 + $199 + 9 × $299 |
| Medicare GLP-1 Bridge | $600 to $650 | 12 or 13 fills × $50 |
Several of these prices end on December 31, 2026, including Wegovy's $199 fills, Foundayo's reduced prices and every Lilly savings card, so a year that runs into 2027 may cost more. Pens and vials are counted as 13 fills of 28 days, pills as 12 bottles of 30 tablets. The Zepbound row assumes a dose above 5 mg from the third month; staying at 5 mg comes to $5,087. For compounded tirzepatide, our price index found a median of about $141 a month over a year.
What Changes the Price of a GLP-1?
Seven things move your monthly cost, often more than the drug you pick:
- The form. Pills start at $149. Zepbound vials and KwikPens have self-pay prices, while LillyDirect prices single-dose Zepbound pens for insured patients.
- Your dose. Self-pay prices for Zepbound, Ozempic, the Wegovy pill and Foundayo rise with the dose. Mounjaro and Trulicity cost the same for all doses, and list prices don't change with the dose.
- Refill timing. Zepbound's $449 price and Foundayo's $299 top-dose price need a refill within 45 days.
- New-patient offers. Wegovy's and Ozempic's $199 fills apply only to a new patient's first two fills.
- The "month." A 28-day supply means 13 fills a year, not 12.
- Your plan. The drug's tier, your deductible, coinsurance tied to list price, prior authorization and the approved use on your prescription all change what insurance pays.
- Program fees. Some telehealth programs charge a membership, visit or lab fee on top of the medicine.
Will GLP-1s Get Cheaper in 2027?
List prices will fall for Novo Nordisk's semaglutide drugs, but self-pay prices aren't set to change. On January 1, 2027, Novo Nordisk will lower the list price of Wegovy, Ozempic and Rybelsus to $675 a month for all doses, about 50% lower for Wegovy and 35% lower for Ozempic. The company says the cut is meant for people whose costs are tied to list price, such as those on high-deductible plans or paying coinsurance, and that "these changes in list price do not have an impact on direct-to-patient, self-pay prices" (Novo Nordisk).
Other dates to watch:
- December 31, 2026: Lilly's Zepbound, Mounjaro, Foundayo and Trulicity savings cards expire, Foundayo's reduced 2.5 mg and 5.5 mg prices end, and the $199 new-patient fills of Wegovy and Ozempic end. As of November 2026, the makers had not published 2027 terms.
- Late January 2027: last shipments of Saxenda to wholesalers.
- December 31, 2027: the Medicare GLP-1 Bridge ends.
How Can You Lower Your GLP-1 Cost?
The biggest savings come from using the right program for your coverage. In order:
- Check your coverage first. If your plan covers your GLP-1, the maker's savings card can bring it to $25. Lilly's cards allow that price for up to a 3-month fill.
- Use the maker's self-pay price if your plan says no, and refill on time to keep the lower prices.
- Ask about Medicare's Bridge if you have Part D and meet its BMI rules.
- Use pre-tax money. Prescription medicines are qualified medical expenses under IRS Publication 502, so HSA and FSA funds may be eligible. Check with your plan administrator and read your savings card's terms (how HSA and FSA rules apply to GLP-1s).
- Compare compounded options on the full monthly cost, if a brand isn't affordable. Compounded semaglutide and tirzepatide are a lower-cost cash option, not FDA-approved and not equivalent to a brand, and a licensed provider decides whether one fits you.
- Skip "research use" products. The FDA warns against unapproved semaglutide and tirzepatide sold "for research purposes" or "not for human consumption," which are of unknown quality (FDA).
The Bottom Line
As of November 2026, a GLP-1 costs about $650 to $1,350 a month at list price, $149 to $499 through the makers' self-pay programs, as little as $25 with commercial coverage and a savings card, and $50 through the Medicare GLP-1 Bridge for Part D members who qualify. A year of brand-name treatment at self-pay prices runs about $3,200 to $6,500. Compounded semaglutide and tirzepatide usually cost less than brand-name injections, but they are not FDA-approved. Many offers end December 31, 2026, and Novo Nordisk's list prices fall to $675 on January 1, 2027, so check your exact price for your dose before you fill.
Frequently Asked Questions
Compounded Semaglutide $89/mo or Tirzepatide $120/mo
MaxLife compounded semaglutide $89 a month and tirzepatide $120 a month, flat. All-inclusive, no membership fee, the same price at every dose. A licensed provider decides.
Check Your EligibilityThis article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Individual results vary. Pricing, insurance coverage, and compounding regulations described here are subject to change; verify current details with your insurance provider, the manufacturer, or your prescriber before making treatment decisions. Compounded medications are not FDA-approved.
Why trust our experts

April Foster, DO MPH
Reviewer
Board Certified Family Medicine Physician licensed nationwide providing collaborative oversight to NPs, PAs, and RN. Also specializing in telemedicine services nationwide.
Sources
- TrumpRx.gov: Wegovy pen, list price (WAC) and self-pay price
- TrumpRx.gov: Wegovy pill, list price (WAC) and self-pay prices
- TrumpRx.gov: Zepbound vial, list price (WAC) and self-pay prices
- TrumpRx.gov: Mounjaro, list price (WAC) and self-pay price
- TrumpRx.gov: Foundayo, list price (WAC) and self-pay prices
- TrumpRx.gov: Trulicity, list price (WAC) and self-pay price
- NovoCare: Ozempic list price explained
- NovoCare: Saxenda list price and discontinuation notice
- NovoCare Pharmacy: Wegovy self-pay prices and savings offer
- NovoCare Pharmacy: Ozempic self-pay prices and savings offer
- LillyDirect: Zepbound self-pay prices (vial and KwikPen)
- LillyDirect: Mounjaro self-pay price
- LillyDirect: Foundayo self-pay prices
- LillyDirect: Foundayo savings card terms
- LillyDirect: Trulicity self-pay price
- Lilly: Zepbound coverage, savings card and self-pay terms
- Lilly: Mounjaro savings card terms
- Lilly: Trulicity savings card terms
- Novo Nordisk (Feb 24, 2026): list price of Wegovy, Ozempic and Rybelsus to fall to $675 on January 1, 2027
- Novo Nordisk (Feb 4, 2026): FDA approves the Ozempic name for semaglutide tablets
- Novo Nordisk (Mar 31, 2026): Wegovy subscription program through telehealth providers
- CMS: Medicare GLP-1 Bridge
- Medicare.gov: Weight loss drugs (Medicare GLP-1 Bridge coverage and eligibility)
- KFF: 2026 Employer Health Benefits Survey
- KFF: Medicaid coverage of and spending on GLP-1s
- IRS Publication 502: Medical and Dental Expenses
- FDA: Concerns with unapproved GLP-1 drugs used for weight loss
Update History
- November 17, 2026 — New article.
- November 17, 2026 — New article.
- November 17, 2026 — New article.

Semaglutide Cost: Wegovy, Ozempic and Compounded Prices Per Month
August 20, 202614 min

Tirzepatide Cost: Price Per Month With and Without Insurance
August 20, 202614 min

Weight Loss Drugs Covered by Insurance: What to Know
August 20, 202614 min

Can You Use an HSA or FSA for Tirzepatide and Other GLP-1s?
November 15, 202611 min
